Published in Oncotarget on November 26, 2016
Single cell sequencing: a distinct new field. Clin Transl Med (2017) 0.75
Intratumor and Intertumor Heterogeneity in Melanoma. Transl Oncol (2017) 0.75
Single-Cell mRNA Sequencing in Cancer Research: Integrating the Genomic Fingerprint. Front Genet (2017) 0.75
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A (2005) 167.46
Fast gapped-read alignment with Bowtie 2. Nat Methods (2012) 83.79
TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 81.13
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol (2010) 75.21
The protein kinase complement of the human genome. Science (2002) 35.36
Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature (2008) 30.29
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67
Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell (2002) 17.32
A landscape of driver mutations in melanoma. Cell (2012) 12.61
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Integrative analysis of 111 reference human epigenomes. Nature (2015) 10.32
The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol Cell Biol (2007) 8.57
Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell (2008) 7.69
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science (2014) 6.09
Genomic Classification of Cutaneous Melanoma. Cell (2015) 3.91
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov (2013) 3.71
Epigenetic reprogramming in cancer. Science (2013) 3.47
Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res (2010) 3.40
Gene expression profiling of primary cutaneous melanoma and clinical outcome. J Natl Cancer Inst (2006) 3.17
The implications of clonal genome evolution for cancer medicine. N Engl J Med (2013) 2.78
RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol Syst Biol (2011) 2.77
Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol (2011) 2.69
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell (2015) 2.57
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov (2014) 2.51
The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol Cell Proteomics (2011) 2.43
Spatial reconstruction of single-cell gene expression data. Nat Biotechnol (2015) 2.31
The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice. Nat Genet (2007) 2.17
Non-genomic and Immune Evolution of Melanoma Acquiring MAPKi Resistance. Cell (2015) 2.12
Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome. Clin Cancer Res (2010) 2.01
EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing. Cancer Discov (2014) 1.99
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science (2016) 1.95
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature (2015) 1.91
High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene (2007) 1.83
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells (2012) 1.70
B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis. PLoS One (2007) 1.65
Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance. J Oncol (2010) 1.63
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma. Nat Commun (2014) 1.48
A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin Cancer Biol (2014) 1.33
The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing. Oncogene (2007) 1.23
The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene. Mol Cell Biol (2005) 1.20
Human cerebral organoids recapitulate gene expression programs of fetal neocortex development. Proc Natl Acad Sci U S A (2015) 1.20
freeIbis: an efficient basecaller with calibrated quality scores for Illumina sequencers. Bioinformatics (2013) 1.17
Molecular profiling reveals low- and high-grade forms of primary melanoma. Clin Cancer Res (2012) 1.17
Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment. Clin Cancer Res (2015) 1.10
Major therapeutic developments and current challenges in advanced melanoma. Br J Dermatol (2014) 1.07
Single-cell gene expression signatures reveal melanoma cell heterogeneity. Oncogene (2014) 1.01
Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis. J Invest Dermatol (2013) 1.00
Robust extraction of functional signals from gene set analysis using a generalized threshold free scoring function. BMC Bioinformatics (2009) 0.98
Transcriptional profiles of unirradiated or UV-irradiated human cells expressing either the cancer-prone XPB/CS allele or the noncancer-prone XPB/TTD allele. Oncogene (2005) 0.97
Expression cartography of human tissues using self organizing maps. BMC Bioinformatics (2011) 0.96
Genetic and functional diversity of propagating cells in glioblastoma. Stem Cell Reports (2014) 0.96
KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation. Genome Biol (2014) 0.95
deML: robust demultiplexing of Illumina sequences using a likelihood-based approach. Bioinformatics (2014) 0.93
Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking? Lab Invest (2013) 0.92
Palbociclib: first global approval. Drugs (2015) 0.92
Mining SOM expression portraits: feature selection and integrating concepts of molecular function. BioData Min (2012) 0.87
Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma. Clin Cancer Res (2015) 0.86
The human melanoma side population displays molecular and functional characteristics of enriched chemoresistance and tumorigenesis. PLoS One (2013) 0.85
The role of MEK inhibitors in the treatment of metastatic melanoma. Curr Opin Oncol (2014) 0.85
Portraying the Expression Landscapes of B-CellLymphoma-Intuitive Detection of Outlier Samples and of Molecular Subtypes. Biology (Basel) (2013) 0.83
oposSOM: R-package for high-dimensional portraying of genome-wide expression landscapes on bioconductor. Bioinformatics (2015) 0.80
Single-cell analysis of lung adenocarcinoma cell lines reveals diverse expression patterns of individual cells invoked by a molecular target drug treatment. Genome Biol (2015) 0.80
Epigenetic Heterogeneity of B-Cell Lymphoma: Chromatin Modifiers. Genes (Basel) (2015) 0.78
Controlling the Balance of Fibroblast Proliferation and Differentiation: Impact of Thy-1. J Invest Dermatol (2015) 0.77
Trametinib in the treatment of melanoma. Expert Opin Biol Ther (2015) 0.76